Distribution of grey matter atrophy in Huntington’s disease patients: A combined ROI-based and voxel-based morphometric study
暂无分享,去创建一个
Anne-Catherine Bachoud-Lévi | Philippe Hantraye | Philippe Remy | Gwenaëlle Douaud | Véronique Gaura | F. Lethimonnier | M.-J. Santiago Ribeiro | R. Maroy | Pierre Krystkowiak | Christophe Verny | Philippe Damier | G. Douaud | P. Remy | R. Maroy | P. Damier | P. Krystkowiak | A. Bachoud-Lévi | M. Ribeiro | P. Hantraye | F. Lethimonnier | C. Verny | V. Gaura | M. Ribeiro
[1] S. Fahn,et al. Huntington disease , 1979, Neurology.
[2] A Weindl,et al. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. , 2004, Brain : a journal of neurology.
[3] Terry L. Jernigan,et al. Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases , 1991, Biological Psychiatry.
[4] Fred L. Bookstein,et al. “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.
[5] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[6] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[7] G D Pearlson,et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. , 1996, Archives of neurology.
[8] E Maran,et al. Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntington's Disease , 1990, Journal of neuropathology and experimental neurology.
[9] G. W. Bruyn,et al. Neuropathological changes of the nucleus accumbens in Huntington's chorea , 2004, Acta Neuropathologica.
[10] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[11] D. Zee,et al. Ocular motor abnormalities in Huntington's disease , 1997, Vision Research.
[12] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Penney,et al. Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical study , 2004, Journal of Chemical Neuroanatomy.
[14] D. Mann,et al. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy , 2004, Acta Neuropathologica.
[15] Alberto Beltramello,et al. A comparison between the accuracy of voxel‐based morphometry and hippocampal volumetry in Alzheimer's disease , 2004, Journal of magnetic resonance imaging : JMRI.
[16] Karl J. Friston,et al. Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias , 2002, NeuroImage.
[17] J Kassubek,et al. Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[18] E. Wanker,et al. Huntington's Disease Intranuclear Inclusions Contain Truncated, Ubiquitinated Huntingtin Protein , 1999, Experimental Neurology.
[19] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[20] Wilhelm Gaus,et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.
[21] K. F. Schroeder,et al. Morphometric studies of the neuropathological changes in choreatic diseases , 1976, Journal of the Neurological Sciences.
[22] R. Steen,et al. Age‐related changes in proton T1 values of normal human brain , 1995, Journal of magnetic resonance imaging : JMRI.
[23] A. Dale,et al. Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.
[24] G. Sedvall,et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. , 1997, Brain : a journal of neurology.
[25] D J Brooks,et al. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. , 1996, Brain : a journal of neurology.
[26] A. Young,et al. Impaired recognition of disgust in Huntington's disease gene carriers. , 1997, Brain : a journal of neurology.
[27] Jean-Francois Mangin,et al. Population classification based on structural morphometry of cortical sulci , 2004, 2004 2nd IEEE International Symposium on Biomedical Imaging: Nano to Macro (IEEE Cat No. 04EX821).
[28] R. Wurtz,et al. Role of the basal ganglia in the initiation of saccadic eye movements. , 1986, Progress in brain research.
[29] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[30] E. Siemers,et al. Rate of functional decline in Huntington’s disease , 2000, Neurology.
[31] J. Brandt,et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. , 1999, Brain : a journal of neurology.
[32] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[33] Karl J. Friston,et al. Cerebral Asymmetry and the Effects of Sex and Handedness on Brain Structure: A Voxel-Based Morphometric Analysis of 465 Normal Adult Human Brains , 2001, NeuroImage.
[34] P Aebischer,et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. , 2004, Human gene therapy.
[35] Jean-Francois Mangin,et al. A structural browser for human brain mapping , 2000, NeuroImage.
[36] S. Folstein,et al. Early Loss of Neostriatal Striosome Neurons in Huntington's Disease , 1995, Journal of neuropathology and experimental neurology.
[37] Lewis D. Griffin,et al. Zen and the art of medical image registration: correspondence, homology, and quality , 2003, NeuroImage.
[38] Lutz Jäncke,et al. Brain size and grey matter volume in the healthy human brain , 2002, Neuroreport.
[39] G. Pearlson,et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.
[40] Anne-Catherine Bachoud-Lévi,et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.
[41] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[42] Marian DiFiglia,et al. Huntington Disease , 1998, Journal of neuropathology and experimental neurology.
[43] P. K. Morrish,et al. Regional changes in [ 18 F]dopa metabolism in the striatum in Parkinson's disease , 2005 .
[44] Karl J. Friston,et al. Voxel-based morphometry , 2007 .
[45] C D Good,et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.
[46] N Makris,et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat , 2001, Neurology.
[47] Laura L. Murray,et al. Productive syntax abilities in Huntington's and Parkinson's diseases , 2001, Brain and Cognition.
[48] V. Calhoun,et al. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia , 2005, Schizophrenia Research.
[49] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[50] H. Kremer,et al. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease , 1991, Neuroscience Letters.
[51] A. Young,et al. Impaired recognition and experience of disgust following brain injury , 2000, Nature Neuroscience.
[52] Karl J. Friston,et al. Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.
[53] D. Perrett,et al. Loss of disgust. Perception of faces and emotions in Huntington's disease. , 1996, Brain : a journal of neurology.
[54] Bernard Mazoyer,et al. Finger tapping, handedness and grey matter amount in the Rolando's genu area , 2005, NeuroImage.
[55] Jane S. Paulsen,et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.
[56] M. Panas,et al. Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia , 2005, Annals of neurology.
[57] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.